Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 5
2008 8
2009 11
2010 16
2011 11
2012 10
2013 12
2014 27
2015 6
2016 3
2017 3
2018 1
2019 1
2020 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 17722505

103 results

Results by year

Filters applied: . Clear all
Page 1
Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Keystone E, Heijde Dv, Mason D Jr, Landewé R, Vollenhoven RV, Combe B, Emery P, Strand V, Mease P, Desai C, Pavelka K. Keystone E, et al. Arthritis Rheum. 2008 Nov;58(11):3319-29. doi: 10.1002/art.23964. Arthritis Rheum. 2008. PMID: 18975346 Free article. Clinical Trial.
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.
Fleischmann R, Vencovsky J, van Vollenhoven RF, Borenstein D, Box J, Coteur G, Goel N, Brezinschek HP, Innes A, Strand V. Fleischmann R, et al. Ann Rheum Dis. 2009 Jun;68(6):805-11. doi: 10.1136/ard.2008.099291. Epub 2008 Nov 17. Ann Rheum Dis. 2009. PMID: 19015206 Free PMC article. Clinical Trial.
Certolizumab pegol.
Goel N, Stephens S. Goel N, et al. MAbs. 2010 Mar-Apr;2(2):137-47. doi: 10.4161/mabs.2.2.11271. MAbs. 2010. PMID: 20190560 Free PMC article. Review.
CDP-870 (certolizumab) in rheumatoid arthritis.
Kaushik VV, Moots RJ. Kaushik VV, et al. Expert Opin Biol Ther. 2005 Apr;5(4):601-6. doi: 10.1517/14712598.5.4.601. Expert Opin Biol Ther. 2005. PMID: 15934837 Review.
Certolizumab for rheumatoid arthritis.
Markatseli TE, Papagoras C, Nikoli A, Voulgari PV, Drosos AA. Markatseli TE, et al. Clin Exp Rheumatol. 2014 May-Jun;32(3):415-23. Epub 2014 Jan 20. Clin Exp Rheumatol. 2014. PMID: 24447441 Review.
[Certolizumab pegol].
Delgado Frías E, Díaz González JF. Delgado Frías E, et al. Reumatol Clin. 2011 Mar;6S3:S7-11. doi: 10.1016/j.reuma.2010.11.011. Epub 2011 Mar 23. Reumatol Clin. 2011. PMID: 21794764 Free article. Spanish.
103 results